Universally, there’s the belief that the availability of a Covid-19 vaccine will break the spell of suffering and we can finally rid ourselves of our masks. But the last mile from ‘vaccine’ to ‘vaccination’ must be trekked before our world can truly start to become safe, and that journey is fraught with challenges.
Some of these problems, though complex, are well-defined – like connecting the dots between vaccine providers, distributors and consumers, nurturing a cold supply chain framework or even streamlining the broad spectrum of vaccine management from prioritization and administration, all the way to adverse effect monitoring. In fact, we recently announced a software solution that does exactly that. Then again, not all problems, in this context, are as well-framed.